Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
4.705
-0.135 (-2.79%)
Dec 27, 2024, 12:14 PM EST - Market open
Fulcrum Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Net Income | -17.91 | -97.34 | -109.87 | -80.85 | -70.82 | -82.68 | Upgrade
|
| Depreciation & Amortization | 1.73 | 2.17 | 2.41 | 2.52 | 2.38 | 2.05 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 25.59 | Upgrade
|
| Loss (Gain) From Sale of Investments | -4.78 | -5.99 | 0.15 | 0.67 | -0.07 | - | Upgrade
|
| Stock-Based Compensation | 15.53 | 14.8 | 13.35 | 11.07 | 7.35 | 4.22 | Upgrade
|
| Other Operating Activities | - | - | -0 | - | - | - | Upgrade
|
| Change in Accounts Receivable | -3.08 | -0.31 | 3.41 | -1.11 | -2.53 | - | Upgrade
|
| Change in Accounts Payable | 0.29 | -0.85 | -1.18 | 0.97 | 1.77 | 0.8 | Upgrade
|
| Change in Unearned Revenue | -0.33 | -0.93 | -3.78 | -13.17 | 7.88 | 10 | Upgrade
|
| Change in Other Net Operating Assets | -0.06 | -2.52 | -1.55 | 1.41 | 0.38 | 0.52 | Upgrade
|
| Operating Cash Flow | -8.62 | -90.97 | -97.05 | -78.48 | -53.66 | -39.48 | Upgrade
|
| Capital Expenditures | -0.12 | -0.51 | -1.96 | -1.71 | -1.34 | -0.94 | Upgrade
|
| Investment in Securities | 48.45 | -36.18 | 14.38 | -127.96 | -55.8 | - | Upgrade
|
| Investing Cash Flow | 48.32 | -36.69 | 12.41 | -129.67 | -57.14 | -0.94 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -0.02 | -0.05 | -0.05 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | -0.02 | -0.05 | -0.05 | Upgrade
|
| Issuance of Common Stock | 2.95 | 118.12 | 84.32 | 186.53 | 71.38 | 64.42 | Upgrade
|
| Other Financing Activities | - | - | - | - | -0.19 | -0.03 | Upgrade
|
| Financing Cash Flow | 2.95 | 118.12 | 84.32 | 186.51 | 71.13 | 64.34 | Upgrade
|
| Net Cash Flow | 42.66 | -9.54 | -0.31 | -21.64 | -39.66 | 23.92 | Upgrade
|
| Free Cash Flow | -8.74 | -91.47 | -99.01 | -80.19 | -55 | -40.43 | Upgrade
|
| Free Cash Flow Margin | -10.81% | -3261.07% | -1561.23% | -418.47% | -623.34% | - | Upgrade
|
| Free Cash Flow Per Share | -0.14 | -1.49 | -2.20 | -2.27 | -2.17 | -3.66 | Upgrade
|
| Cash Interest Paid | - | - | - | - | 0 | 0.01 | Upgrade
|
| Levered Free Cash Flow | -4.82 | -56.72 | -58.12 | -47.54 | -24.98 | -41.47 | Upgrade
|
| Unlevered Free Cash Flow | -4.82 | -56.72 | -58.12 | -47.54 | -24.98 | -41.47 | Upgrade
|
| Change in Net Working Capital | 4.21 | 4.02 | 1.84 | 8.75 | -11.39 | -5.84 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.